Prostate Cancer Polygenic Score Does Not Improve High-Grade Disease Prediction Over Clinical Factors
Researchers found that adding genetic risk score data did not improve their ability to predict aggressive prostate cancer cases over conventional risk stratification approaches.
Illumina, Nashville Biosciences Ink WGS Agreement With Amgen for African American Cohort
As part of the agreement, Amgen subsidiary DeCode Genetics will perform WGS on 35,000 DNA samples from VUMC's biobank using Illumina platforms.
CardioVar Consortium Wins $8.2M From NHLBI to Map Heart Disease Variants, Functional Effects
The investigators hope to eventually create a decision support resource with utility for physicians evaluating genetic test results in heart disease patients.
Variants Linked to Microbiome Traits Implicated in Range of Traits, Conditions
A phenome-wide association study focused on microbiome-associated variants led to conditions ranging from skin disease to diabetes, heart disease, or multiple sclerosis.
The bioinformatics firm hopes its AI and "NASA-style" command center will make it easier to get cancer patients into NGS labs and improve trial matching.